Susquehanna Growth Equity

Susquehanna Growth Equity is a Bala Cynwyd, Pennsylvania-based growth investor backing software companies across multiple sectors, with healthcare exposure focused on health IT and digital health. The firm operates as a private equity investor with venture characteristics, taking minority and majority growth positions in established software businesses with meaningful revenue and margin profiles. Limited public information is available on a dedicated healthcare partner allocation, suggesting health deals are evaluated through the firm’s broader software investing framework. Founders should expect rigorous SaaS-style diligence around growth, retention, and margin metrics.

Check sizes are typically twenty-five million dollars and above, with stage focus on Series B, Series C, and later growth rounds. The firm operates primarily in the United States with selective international exposure, and engages with companies that have moved well beyond product-market fit and are scaling toward profitability or strategic outcomes. Stage focus means SGE is appropriate only for established companies, not early-stage healthcare technology businesses still proving the core thesis.

For founders, SGE is most relevant to growth-stage health IT and digital health software companies with strong gross margins, durable retention, and clear paths to scaled profitability. Teams should be prepared for thorough financial diligence, customer reference work, and discussions about governance, capital structure, and longer-term liquidity strategy. Founders pitching biotech, devices, or capital-intensive care delivery models will not fit. The relationship is best evaluated as a long-arc partnership with growth equity expectations rather than a fast-deploying venture check, and founders should be aligned with that expectation set before engaging.